Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.9 |
mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.0045 | 0.9 |
mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
mRNA | AZD0530 | FIMM | pan-cancer | AAC | 0.016 | 0.9 |
mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
mRNA | AMG-706 | FIMM | pan-cancer | AAC | -0.015 | 0.9 |
mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.0033 | 0.9 |